Loading...
XNAS
OFIX
Market cap629mUSD
Dec 05, Last price  
15.90USD
1D
0.00%
1Q
9.28%
Jan 2017
-56.05%
Name

Orthofix Medical Inc

Chart & Performance

D1W1MN
XNAS:OFIX chart
P/E
P/S
0.79
EPS
Div Yield, %
Shrs. gr., 5y
15.07%
Rev. gr., 5y
11.69%
Revenues
799m
+7.08%
313,304,000365,359,000490,323,000519,675,000545,635,000564,370,000578,988,000462,320,000400,534,000402,277,000396,489,000409,788,000433,823,000453,042,000459,955,000406,562,000464,479,000460,713,000746,641,000799,491,000
Net income
-126m
L-16.78%
73,402,000-7,042,00010,968,000-228,554,00024,472,00044,208,000-1,073,00051,295,000-28,475,000-8,537,000-2,809,0003,056,0006,223,00013,811,000-28,462,0002,517,000-38,379,000-19,749,000-151,395,000-125,997,000
CFO
26m
P
106,673,0008,171,00021,496,00026,770,00049,970,00042,474,00064,781,00011,206,00067,445,00050,958,00043,224,00044,707,00053,341,00049,918,00032,033,00074,272,00018,475,000-11,538,000-45,753,00025,790,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
IPO date
Apr 24, 1992
Employees
1,092
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT